Medical cannabis Company
Aleafia Health Inc. (TSX: V.ALEF,
OTCQB: CAMDF,
Forum) announced Tuesday that it has formalized a strategic genetic supply agreement with another medical cannabis Company,
CannTrust.
Under this agreement, Aleafia will receive various strains of starter genetics for its first licensed production facility. As a preferred partner, CannTrust also has the ability to purchase product from Aleafia's harvest to support its patient base.
More information can be found
here.
Aleafia Health was in the news recentlywhen the Company added four new appointees to its executive team to support its expansion goals.
FULL DISCLOSURE: Aleafia Inc. is a paid client of Stockhouse Publishing.